fda glp-1 safety alert october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Societies take stand against off-brand

Eight weeks of exposure to WD at middle-age increased brain cytokines in a sex-dependent manner, in which females demonstrated increased inflammation in the amygdala in response to WD, whereas males trended towards increased levels in the ventral hippocampus

2025;328(3):H450H461

Hassan Ibrahim takes a personalized approachduring your consultation, hell review your medical history, weight loss goals, lifestyle, and any previous treatments

Clinical trials show 15-21% body weight loss depending on the medication and dose

In an interview with CBS Sunday Morning, Winfrey spoke about how learning that obesity is a disease helped her stop seeing her weight as a personal failure

Improve your mental health